BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 25733061)

  • 1. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
    Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
    Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helios: still behind the clouds.
    Thornton AM; Shevach EM
    Immunology; 2019 Nov; 158(3):161-170. PubMed ID: 31517385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.
    Bin Dhuban K; d'Hennezel E; Nashi E; Bar-Or A; Rieder S; Shevach EM; Nagata S; Piccirillo CA
    J Immunol; 2015 Apr; 194(8):3687-96. PubMed ID: 25762785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4
    Yang M; Liu Y; Mo B; Xue Y; Ye C; Jiang Y; Bi X; Liu M; Wu Y; Wang J; Olsen N; Pan Y; Zheng SG
    Cell Physiol Biochem; 2019; 52(5):1178-1192. PubMed ID: 30990587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells.
    Getnet D; Grosso JF; Goldberg MV; Harris TJ; Yen HR; Bruno TC; Durham NM; Hipkiss EL; Pyle KJ; Wada S; Pan F; Pardoll DM; Drake CG
    Mol Immunol; 2010 Apr; 47(7-8):1595-600. PubMed ID: 20226531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helios Deficiency Predisposes the Differentiation of CD4
    Skadow M; Penna VR; Galant-Swafford J; Shevach EM; Thornton AM
    J Immunol; 2019 Jul; 203(2):370-378. PubMed ID: 31167776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics.
    Mijnheer G; Prakken BJ; van Wijk F
    Curr Opin Rheumatol; 2013 Mar; 25(2):260-7. PubMed ID: 23274520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helios Controls a Limited Subset of Regulatory T Cell Functions.
    Sebastian M; Lopez-Ocasio M; Metidji A; Rieder SA; Shevach EM; Thornton AM
    J Immunol; 2016 Jan; 196(1):144-55. PubMed ID: 26582951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helios
    Thornton AM; Lu J; Korty PE; Kim YC; Martens C; Sun PD; Shevach EM
    Eur J Immunol; 2019 Mar; 49(3):398-412. PubMed ID: 30620397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated level of circulating CD4
    Liu C; Guan Z; Zhao L; Song Y; Wang H
    Mod Rheumatol; 2017 Jul; 27(4):630-637. PubMed ID: 27538522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.
    Thornton AM; Korty PE; Tran DQ; Wohlfert EA; Murray PE; Belkaid Y; Shevach EM
    J Immunol; 2010 Apr; 184(7):3433-41. PubMed ID: 20181882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
    McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helios enhances the preferential differentiation of human fetal CD4
    Ng MSF; Roth TL; Mendoza VF; Marson A; Burt TD
    Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31757834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
    Tada Y; Ono N; Suematsu R; Tashiro S; Sadanaga Y; Tokuda Y; Ono Y; Nakao Y; Maruyama A; Ohta A; Koarada S
    BMC Musculoskelet Disord; 2016 Jul; 17():290. PubMed ID: 27421886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
    Elkord E; Abd Al Samid M; Chaudhary B
    Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.